Previous 10 | Next 10 |
Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...
Dermata Therapeutics press release (NASDAQ:DRMA): FY GAAP EPS of -$2.43 beats by $0.75. Cash of $10.8 million as of December 31, 2021, compared to $0.5 million as of December 31, 2020. Shares +4.54% PM. For further details see: Dermata Therapeutics GAAP EPS of -$2.43 beats by $0.75
DMT310 Phase 2 rosacea trial is over two-thirds enrolled with topline results expected in H2 2022 DMT310 Phase 2 psoriasis trial to start H1 2022, with topline results expected in H1 2023 DMT310 Phase 3 moderate-to-severe acne trials planned for H1 2023 SAN DIEGO, CA / ACCESSWI...
SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced that the Company will be participating in the 2022 M...
Gainers: NeuroSense Therapeutics (NRSN) +289%. Yumanity Therapeutics (YMTX) +36%. Dermata Therapeutics (SERA) +30%. Sera Prognostics (DRMA) +21%. Creative Medical Technology Holdings (CELZ) +20%. Losers: Vallon Pharmaceuticals (VLON) -70%. Connect Biopharma Holdings (CNTB) -22%. Imm...
Gainers: Dermata (NASDAQ:DRMA) +25%. IronNet (NYSE:IRNT) +25%. China Online Education (NYSE:COE) +25%. Greenwich LifeSciences (NASDAQ:GLSI) +25%. CleanSpark (NASDAQ:CLSK) +24%. Ebang International Holdings (NASDAQ:EBON) +22%. Lufax Holding (NYSE:LU) +22%. Vaccinex (NASDAQ:VCNX) +21%. The Vale...
Gainers: Dermata Therapeutics (NASDAQ:DRMA) +35%. Innoviva (NASDAQ:INVA) +11%. Mainz Biomed (NASDAQ:MYNZ) +9%. Regional Health Properties (NYSE:RHE) +9%. Envista Holdings (NYSE:NVST) +8%. Losers: InfuSystem Holdings (NYSE:INFU) -22%. Sea...
Buying Penny Stocks Today? Here’s What You Need to Know As we get started on another day of trading penny stocks and blue chips, there is a lot for investors to consider. Because penny stocks are so speculative, understanding exactly what is going on in the stock market will ...
IronNet IRNT +26% on multi-year pact with GCC country. Dermata Therapeutics (NASDAQ:DRMA) +28%. Twilio TWLO +19% on Q4 results. Preferred Apartment Communities APTS +16% report of takeover interest. Datadog DDOG +14% on Q4 results. Marqeta MQ +13% names...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Rub that sleep out our your eyes because we’re going over the biggest pre-market stock movers for Thursday! Source: oneinchpunch/Shutterstock.com We’re still knee-deep in earnings...
News, Short Squeeze, Breakout and More Instantly...
Dermata Therapeutics Inc. Company Name:
DRMA Stock Symbol:
NASDAQ Market:
Dermata Therapeutics Inc. Website:
SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreement...
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track - - Dermata continues discussions with potential botulinum toxin partners for DMT410 - - Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis - SAN...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...